Safe & Green Development Bolsa (NASDAQ: SGD)

Últimas noticias sobre Safe & Green Development (NASDAQ:SGD) Bolsa

Safe & Green Development

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

Box,Headquarters,In,Redwood,City,,California,,Usa,-,June,8,

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BROG

CETX

CODI

GLXY

IFRX

IMNN

JFBR

JOBY

LAES

LVWR

NEHC

OKTA

PMAX

SGBX

SONN

WORX

Descubre qué acciones destacan en el premercado de EE. UU., desde subidas explosivas como Box hasta caídas por anuncios clave.

Las acciones de Box se disparan un 12%; Aquí están 20 acciones que se mueven en el premercado

APLD

AZTR

CRKN

CVGW

GCTK

GLAC

HSDT

LFWD

MASS

ORKA

QBTS

QUBT

RIME

VMAR

VRME

Descubre las acciones ganadoras y perdedoras en el premercado, con Vision Marine liderando un aumento del 45%.

Las acciones de Vision Marine (VMAR) se disparan un 45%; 20 acciones que se están moviendo en premercado

Safe and Green Development Corporation - Common Stock

Safe & Green Development Corp

SAN-IN GODO BK LTD by San-In Godo Bank Ltd.

San-in Godo Bank Ltd

SGD Holdings Ltd

AI METAVERSE HOLDINGS CP by AI Metaverse Holdings Corp

AI Metaverse Holdings Corp

Sprott Junior Gold Miners ETF

Sprott Gold Miners ETF

Raymond James analyst Srini Pajjuri reiterates KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Outperform and raises the price target from $850 to $950.

Price Target

Reiteration

Analyst Ratings

KLAC

Raymond James Reiterates Outperform on KLA, Raises Price Target to $950

Barclays analyst Brandt Montour maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Overweight and raises the price target from $25 to $31.

NCLH

Barclays Maintains Overweight on Norwegian Cruise Line, Raises Price Target to $31

Wedbush analyst Alicia Reese maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Outperform and raises the price target from $142 to $165.

RBLX

Wedbush Maintains Outperform on Roblox, Raises Price Target to $165

On Friday,&nbsp;Regeneron Pharmaceuticals&nbsp;Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) reported second-quarter adjusted earnings of $12.89 per share, up 12% year-over-year, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus of $8.57</a>.
The&nbsp;company reported sales&nbsp;of $3.68 billion, up 4% year over year, beating the <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/46785919/regeneron-pharmaceuticals-likely-to-report-lower-q2-earnings-these-most-accura" rel="noreferrer noopener">consensus of $3.29 billion</a>.
In the second quarter, U.S. net sales for Eylea HD&nbsp;and Eylea&nbsp;decreased 25% year-over-year to $1.15&nbsp;billion, including $393 million from Eylea HD and $754 million from Eylea.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45726872/regeneron-experimental-weight-loss-drug-with-novo-nordisks-wegovy-helps-preserve-lean-mass-in-mid-stage-study" rel="noreferrer noopener">Regeneron&#8217;s Obesity Trial With Novo Nordisk&#8217;s Wegovy Hits Lean Target</a>
Net product sales of Eylea HD increased in the second quarter of 2025, compared to the second quarter of 2024, due to higher sales volumes driven by increased demand.
Net product sales of EYLEA were negatively impacted by lower sales volumes due to continued competitive pressures, loss in market share to compounded bevacizumab due to patient affordability constraints, continued transition of patients to EYLEA HD, and a lower net selling price.
Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) collaboration revenue increased, due to the company&#8217;s share of profits from the commercialization of antibodies, which were $1.282 billion and $988&nbsp;million in the second quarter of 2025 and 2024, respectively.
The change in the company&#8217;s share of profits from the commercialization of antibodies was driven by higher profits associated with an increase in Dupixent sales.
<h2 class="wp-block-heading">Pipeline Update</h2>
In its earnings press release, Regeneron said it expects regulatory approvals to be delayed for its currently pending U.S. Food and Drug Administration (FDA) applications for EYLEA HD (pre-filled syringe, every-four-week dosing, and for macular edema following retinal vein occlusion), which have <a target="_blank" href="https://www.benzinga.com/pressreleases/25/08/g46788448/regeneron-reports-second-quarter-2025-financial-and-operating-results" rel="noreferrer noopener">PDUFA dates in August 2025</a>.
The anticipated delay concerns observations from an FDA general site inspection at the filler for EYLEA HD in these regulatory applications, Catalent Indiana LLC, recently acquired by Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>).
The inspection was completed in mid-July and was not specific to EYLEA HD. Novo has communicated with the FDA and expects to submit its response next week.
Based on the company&#8217;s review of the observations, Novo&#8217;s proposed response to the FDA, and the progress the company has made with alternate third-party fillers, the company anticipates an expeditious resolution of the filling issues for EYLEA HD.
The FDA issued a Complete Response Letter (CRL) for the application for odronextamab, a bispecific antibody targeting CD20 and CD3, in relapsed/refractory follicular lymphoma after two or more lines of systemic therapy, which was also impacted by the Catalent site inspection.
<h2 class="wp-block-heading">Outlook</h2>
Regeneron expects a 2025 GAAP gross margin of approximately 83%, compared to the <a href="https://www.benzinga.com/25/04/45079889/regeneron-pharmaceuticals-q1-earnings-falls-short-on-expectations-revises-2025-gross-margin-outlook" target="_blank" rel="noreferrer noopener">prior guidance of 83%–84%</a>.
The company expects an adjusted gross margin of approximately 86%, compared to the&nbsp;prior guidance of 86%–87%.
Price Action:&nbsp;REGN stock is trading higher by 3.77% to $566 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/08/46789863/amazon-post-earnings-decline-totally-wrong-says-analyst-as-ceo-points-out-aws-has-more-demand-than-we-have-capacity" target="_blank" rel="noreferrer noopener">Amazon Post-Earnings Decline &#8216;Totally Wrong,&#8217; Says Analyst As CEO Points Out AWS Has &#8216;More Demand Than We Have Capacity&#8217;</a></li>
</ul>
Photo by Marianne Campolongo via Shutterstock

Biotech

Earnings

Large Cap

Guidance

Health Care

General

REGN

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

Barclays analyst Ross Sandler maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $640 to $810.

Barclays Maintains Overweight on Meta Platforms, Raises Price Target to $810

Raymond James analyst Srini Pajjuir reiterates Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Outperform and raises the price target from $230 to $240.

AAPL

Raymond James Reiterates Outperform on Apple, Raises Price Target to $240

JMP Securities analyst Andrew Boone maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Market Outperform and raises the price target from $180 to $225.

RDDT

JMP Securities Maintains Market Outperform on Reddit, Raises Price Target to $225

Barclays analyst Matthew Bouley maintains Masco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) with a Overweight and raises the price target from $77 to $78.

Barclays Maintains Overweight on Masco, Raises Price Target to $78

Raymond James analyst Ryan Deschner maintains Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Outperform and lowers the price target from $52 to $50.

APLS

Raymond James Maintains Outperform on Apellis Pharmaceuticals, Lowers Price Target to $50

<ul>
<li>UNH</li>
<li>AMZN</li>
<li>FIG</li>
<li>GLD</li>
<li>NVDA</li>
<li>RDDT</li>
<li>AAPL</li>
<li>TSLA</li>
<li>AMD</li>
<li>META</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AMZN

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of Aug. 1, 2025 (Via Swaggy Stocks)

Barclays analyst Benjamin Budish maintains LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) with a Overweight and raises the price target from $460 to $463.

LPLA

Barclays Maintains Overweight on LPL Finl Hldgs, Raises Price Target to $463

MCVT

Mill City Ventures Establishes $500M Equity Line Agreement With Alliance Global Partners To Advance SUI Treasury Strategy

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Piper Sandler analyst Brent Bracelin upgraded the rating for AppFolio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) from Neutral to Overweight and raised the price target from $240 to $350. AppFolio shares closed at $267.38 on Thursday. <a href="https://www.benzinga.com/quote/appf/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Ken Newman upgraded Cognex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) from Sector Weight to Overweight and announced a $50 price target. Cognex shares closed at $40.77 on Thursday. <a href="https://www.benzinga.com/quote/cgnx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Noah Zatzkin upgraded the rating for THOR Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) from Underweight to Sector Weight. Thor Industries shares closed at $90.99 on Thursday. <a href="https://www.benzinga.com/quote/tho/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Ike Boruchow upgraded Canada Goose Holdings (TSX:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#TSX">GOOS</a>) from Equal-Weight to Overweight and raised the price target from C$19 to C$20. <a href="https://www.benzinga.com/quote/goos/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying APPF stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/APPF/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="557" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01091628/image-10-1024x557.png" alt="" class="wp-image-1010863" style="width:627px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01091628/image-10-1024x557.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01091628/image-10-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01091628/image-10-768x418.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01091628/image-10.png 1131w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/08/46790607/how-to-earn-500-a-month-from-oneok-stock-ahead-of-q2-earnings">How To Earn $500 A Month From ONEOK Stock Ahead Of Q2 Earnings</a></li>
</ul>
Photo via Shutterstock

Upgrades

APPF

CGNX

GOOS

TSX:GOOS

This AppFolio Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday

JMP Securities analyst Andrew Boone reiterates Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Market Outperform and maintains $285 price target.

JMP Securities Reiterates Market Outperform on Amazon.com, Maintains $285 Price Target

Raymond James analyst Martin Auster reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Outperform and raises the price target from $370 to $424.

ALNY

Raymond James Reiterates Outperform on Alnylam Pharmaceuticals, Raises Price Target to $424

Hudson Global, Inc. (the "Company" or "Hudson RPO") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>), a leading global total talent solutions company, announced today the strategic integration of McKinsey CMO Group ("CMRG"), a boutique firm specializing in recruitment marketing, brand strategy, and talent engagement.
The addition of CMRG's expertise will enable Hudson RPO to further support clients in building stronger employer brands, elevating candidate experiences, and attracting top-tier talent in today's competitive hiring environment. Together, Hudson RPO and CMRG will offer a more holistic suite of services, blending best-in-class recruitment operations with cutting-edge employer branding and engagement strategies.
As part of the integration, Crystal McKinsey, Founder &amp; CEO of CMRG, will join Hudson RPO as the Global Head of Marketing. In this role, she will lead the Company's global marketing efforts and enhance Hudson RPO's capabilities in talent attraction, employer branding, and candidate engagement.

HSON

Hudson RPO Integrates McKinsey CMO Group To Strengthen Employer Branding And Talent Engagement

Barclays analyst Raimo Lenschow maintains Lightspeed Commerce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LSPD#NYSE">LSPD</a>) with a Equal-Weight and raises the price target from $12 to $15.

LSPD

Barclays Maintains Equal-Weight on Lightspeed Commerce, Raises Price Target to $15

Warren Buffett doesn't toss around warnings lightly. But at the 2005 Berkshire Hathaway annual meeting, he made one of his most direct moral declarations: "Anything that would take Social Security payments below their <a href="https://www.benzinga.com/personal-finance/25/02/43564287/warren-buffett-was-once-asked-for-his-opinion-on-social-security-shall-we-call-it-the-government-sponsored-ponzi-scheme-for-retirees">present guaranteed level</a> is a mistake."
That warning is now colliding with the harsh math of 2025.
A new report from the <a href="https://www.crfb.org/blogs/retirees-face-18100-benefit-cut-7-years">Committee for a Responsible Federal Budget</a> projects that the Social Security trust fund will be insolvent by the end of 2032. When that happens, benefits must be slashed to match incoming payroll tax revenue. For over 60 million Americans, that means automatic and immediate cuts—up to 24% in the first year alone.
Don't Miss:
<ul class="wp-block-list">
<li>Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora &amp; MGM—<a href="https://www.benzinga.com/money/rad-intel">Just $0.63 Before NASDAQ Launch</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can <a href="https://www.benzinga.com/money/mode-mobile-2">invest today for just $0.30/share.</a></li>
</ul>
<h2 class="wp-block-heading">A Cut of $18,100 for Retiring Couples</h2>
According to the CRFB's July estimate, a dual-earning couple retiring in early 2033 would see a benefit cut of approximately $18,100 per year. Single-earner couples would lose around $13,600, while low-income dual-earner couples would see an $11,000 cut. Higher-income couples could lose as much as $24,000 annually.
The group warns these reductions would hit all retirees—regardless of income or state—unless Congress enacts structural reforms. Without action, the reductions would begin the moment the trust fund is depleted. The law requires Social Security to operate on a pay-as-you-go basis, so benefits can only be paid from incoming revenue.
The <a href="https://www.ssa.gov/OACT/TR/2025/tr2025.pdf">Social Security Trustees' official 2025 report</a> shows a slightly more optimistic timeline, with projected insolvency by 2033. But both timelines point to the same unavoidable outcome: if nothing changes, cuts are coming.
Trending: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
<h2 class="wp-block-heading">Buffett's Warning Wasn't About Numbers — It Was About Trust</h2>
Buffett's 2005 statement wasn't tied to actuarial tables or funding ratios. It was a broader principle: don't break promises to people who spent their lives paying into the system. Social Security, in his view, was a moral contract.
More than 40% of Americans aged 65 and older rely on Social Security for 90% or more of their income, according to data from the <a href="https://www.ssa.gov/policy/docs/ssb/v77n2/v77n2p1.html">Social Security Administration</a>. For those households, a 24% cut doesn't mean a tighter budget—it means potential poverty.
Buffett has never endorsed cutting benefits. Instead, he's advocated for lifting the payroll tax cap—currently at $168,600 in 2025—so high earners continue contributing on all income. He's also supported raising the full retirement age gradually to reflect longer lifespans, while shielding low-income retirees from any benefit loss.
<h2 class="wp-block-heading">What's Accelerating the Crisis?</h2>
Several forces are pushing the program toward its deadline faster than originally forecasted:
<ul class="wp-block-list">
<li>Tax Policy Changes: <a href="https://www.congress.gov/bill/119th-congress/house-bill/1/text">The One Big Beautiful Bill Act</a> expanded the senior standard deduction and lowered tax collections on benefits. This trimmed future revenue and shaved a full year off the expected solvency timeline, according to CRFB's July analysis.</li>
<li>Demographic Pressure: In 1960, there were 5.1 workers per Social Security recipient. Today, there are just 2.7. By 2035, the figure is <a href="https://www.pgpf.org/article/the-ratio-of-workers-to-social-security-beneficiaries-is-at-a-low-and-projected-to-decline-further/">expected to fall below 2.2</a>.</li>
<li>Cost-of-Living Adjustments: Inflation-linked benefit increases, while essential, further strain the system when paired with stagnant wage growth.</li>
</ul>
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
<h2 class="wp-block-heading">The Clock Is Ticking</h2>
Social Security hasn't seen a major structural overhaul since 1983, when lawmakers raised the full retirement age and began taxing a portion of benefits. While targeted changes were made in 2025—repealing the Windfall Elimination Provision and Government Pension Offset <a href="https://www.benzinga.com/personal-finance/24/12/42678974/a-long-awaited-victory-public-workers-set-to-receive-higher-social-security-benefits-after-senate-passes-social-security-fairness-act">for public-sector retirees</a>—no broad reform has passed to address the growing gap between what the program pays out and what it collects. Meanwhile, life expectancy, benefit payouts, and the number of retirees have continued to surge.
Buffett's warning, made 20 years ago, was a call to preserve guaranteed benefits. In 2025, it reads more like a <a href="https://www.benzinga.com/personal-finance/management/25/07/46624764/social-security-could-run-out-of-funds-by-2030-costing-young-americans-110000-in-lifetime-earnings-report">headline ripped from today's fiscal forecast</a>.
For Americans nearing retirement—or already relying heavily on Social Security—<a href="https://www.benzinga.com/money/smartasset">consulting a financial advisor</a> may help identify strategies to offset potential gaps. While Congress debates solutions, those approaching this cliff may not want to wait to explore their options.
Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Image: Shutterstock

Personal Finance

Warren Buffett Said Social Security Should Never Be Cut — Now Retirees Face Losing $18,000 A Year Unless Congress Moves Before The Clock Runs Out

JMP Securities analyst Trevor Walsh maintains Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) with a Market Outperform and raises the price target from $225 to $250.

JMP Securities Maintains Market Outperform on Cloudflare, Raises Price Target to $250

WIIM

UPLD

Upland Software shares are trading higher after the company reported a Q2 revenue beat.

Dividends

Commodities

Press Releases

Real Estate

Safe and Green Development Corporation Updates Ex-Dividend Date For the Previously Announced Dividend

Safe and Green Development Corporation Releases Unaudited Financial Information for Resource Group

Safe and Green Development Corporation Reports 2024 Year-End Highlights

Safe and Green Development Corporation Releases Letter to Shareholders

Safe and Green Development Corporation Achieves Strategic Milestone with Acquisition of Resource Group

Safe and Green Development Announces Strategic Plan to Unlock Shareholder Value Post-Acquisition

Safe and Green Development Appoints New Board Members Following Acquisition of Resource Group US Holdings LLC

Safe and Green Development Announces Two Sites Appraised at $9.9 Million

Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside

Comments

Safe & Green Development

Noticias

Últimas noticias sobre Safe & Green Development (NASDAQ:SGD) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL